Reuters logo
BRIEF-Shanghai Fosun Pharmaceutical Group says unit acquires 3.9 mln shares in Impax Laboratories
August 31, 2017 / 9:39 AM / 2 months ago

BRIEF-Shanghai Fosun Pharmaceutical Group says unit acquires 3.9 mln shares in Impax Laboratories

Aug 31 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Unit acquired aggregate of 3.9 mln shares in Impax laboratories, for aggregate consideration of about $66.49 mln Source text: (bit.ly/2gsqFHD) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below